Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, and Vaccine Production sent straight to your Inbox. Join over 29,000 lab research professionals who subscribe to FierceVaccines for FREE! Click here to see a sample.

> The prostate cancer vaccine Provenge could be useful in early-stage cancer, according to a study at UCSF. Article

> The UN is backing a mass yellow fever vaccination campaign in northern Cameroon following an outbreak of deaths from the disease. News

> Pediatricians recommend a 'cocoon' strategy--vaccinating the whole family to protect babies. Item

> Vaccines do not lead to Guillain-Barré syndrome. Story

And Finally... The NIH is looking to fund the preclinical development of technologies to improve vaccine effectiveness and/or simplify vaccine delivery. Funding opportunity announcement

Comments

Join 29,000+ InsidersSIGN UP FOR OUR
NEWSLETTER

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

THE LIBRARY: WEBINAR

Achieving Proof-of-Concept Data for Inflammation Drug Studies

| May 2, 2012 - 11am ET / 8am PT

On May 2 at 11 a.m. EST FierceBiotech will host a one-hour webinar with top clinical investigators sharing their insights on the new technologies and strategies now in play to help improve studies for drugs in the inflammation field. Their ideas are relevant for everyone in the R&D world. Register Today!

Featured Jobs

A publication of
FierceMarkets

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email.